Epoetin biosimilars in the management of anemia secondary to chemotherapy in patients with solid tumors, lymphomas, and myelomas: The ORHEO study.
Elisabeth Luporsi-Gely
No relevant relationships to disclose
Pierre-Louis Soubeyran
Consultant or Advisory Role - Hospira (U); Janssen (U); Roche (U)
Honoraria - Hospira; Janssen; Roche
Mauricette Michallet
Consultant or Advisory Role - Hospira (U)